BioNexus Gene Lab Corp (BGLC) stock
BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3090% below fair value
$0.77−0.05 (-6.56%)
Close on Nov 17, 2026Market cap $2.25MP/E –Yield –
BioNexus Gene Lab market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BioNexus Gene Lab's market cap was $2.08M on Nov 11, 2026, against $8.16M a year earlier. Over the last 5 years it ranged from $2.08M to $43.77B, with a median of $86.17M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.08M | -70.7% |
| 2025 | Dec 31, 2025 | $7.10M | -85.9% |
| 2024 | Dec 31, 2024 | $50.26M | -46.7% |
| 2023 | Dec 29, 2023 | $94.30M | -99.5% |
| 2022 | Dec 30, 2022 | $19.80B | -54.7% |
| 2021 | Dec 31, 2021 | $43.77B | +54.3% |
| 2020 | Dec 31, 2020 | $28.35B | – |
See a number that looks wrong?